Navegar por autor "Hernández Ramirez, Vicent"

Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn's disease: Predictors of efficacy in clinical practice

2015- Hernández Ramirez, Vicent; Pereira Bueno, Santos Ramón

Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening

2012- Cubiella Fernández, Joaquín; Zubizarreta Alberdi, Raquel; Hernández Ramirez, Vicent

Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I)

2014- Hernández Ramirez, Vicent

Consulta telemática realizada por Enfermería en pacientes con enfermedad inflamatoria intestinal: Valoración de su capacidad resolutiva y costes

2014- Sanromán Alvarez, Luciano; De Castro Parga, María Luisa; Hernández Ramirez, Vicent; Pineda Mariño, Juan Ramón; Salgado Alvarez, Carlos; [et al.]

Diagnostic performance of fecal immunochemical test and sigmoidoscopy for advanced right-sided colorectal neoplasms

2015- Cubiella Fernández, Joaquín; Castro Novo, María Inés; De Castro Parga, María Luisa; Hernández Ramirez, Vicent; Hermo Brión, José Antonio; [et al.]

East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort

2014- Hernández Ramirez, Vicent; Martínez Ares, David

Effect of Aspirin and Antiplatelet Drugs on the Outcome of the Fecal Immunochemical Test

2013- Cubiella Fernández, Joaquín; Hernández Ramirez, Vicent

Effect of oral anticoagulants on the outcome of faecal immunochemical test

2014- Cubiella Fernández, Joaquín; Hernández Ramirez, Vicent

Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe - An ECCO-EpiCom study

2014- Hernández Ramirez, Vicent; Martínez Ares, David

Fecal immunochemical test accuracy in average-risk colorectal cancer screening

2014- Cubiella Fernández, Joaquín; Castro Novo, María Inés; Iglesias Rodríguez, María Begoña; De Castro Parga, María Luisa; Hernández Ramirez, Vicent; [et al.]

Fecal immunochemical test accuracy in familial risk colorectal cancer screening

2014- Cubiella Fernández, Joaquín; Castro Novo, María Inés; Fernández Seara, José Javier; Álves Pérez, María Teresa; Hernández Ramirez, Vicent; [et al.]

Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort

2014- Hernández Ramirez, Vicent

Incidencia y fenotipo al diagnóstico en la enfermedad inflamatoria intestinal. Resultados del estudio EpiCom en España

2015- Sanromán Alvarez, Luciano; De Castro Parga, María Luisa; Hernández Ramirez, Vicent; Pineda Mariño, Juan Ramón; Rodríguez Prada, José Ignacio; [et al.]

Initial Disease Course and Treatment in an Inflammatory Bowel Disease Inception Cohort in Europe: The ECCO-EpiCom Cohort

2014- Hernández Ramirez, Vicent

Intestinal cancer in inflammatory bowel disease: natural history and surveillance guidelines

2012- Hernández Ramirez, Vicent

Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: Results of a nationwide Spanish registry

2012- Hernández Ramirez, Vicent

Participación en programas de cribado de cáncer colorrectal: ¿qué factores influyen?

2011- Fernández Seara, José Javier; Hernández Ramirez, Vicent; Iglesias Pernas, Felipe; Cid Delgado, Estela

Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening

2014- Cubiella Fernández, Joaquín; Zubizarreta Alberdi, Raquel; Hernández Ramirez, Vicent

Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer

2019- Herreros-Villanueva, M.; Duran-Sanchon, S.; Martin, A. C.; Perez-Palacios, R.; Vila-Navarro, E.; [et al.]

Prevención de la recurrencia post-quirúrgica en la enfermedad de Crohn. ¿Estamos preparados para una estrategia ôtreat-to-targetö?

2015- Hernández Ramirez, Vicent

Repositorio digital RUNA

Navegar por autor "Hernández Ramirez, Vicent"

Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn's disease: Predictors of efficacy in clinical practice ﻿

Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening ﻿

Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I) ﻿

Consulta telemática realizada por Enfermería en pacientes con enfermedad inflamatoria intestinal: Valoración de su capacidad resolutiva y costes ﻿

Diagnostic performance of fecal immunochemical test and sigmoidoscopy for advanced right-sided colorectal neoplasms ﻿

East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort ﻿

Effect of Aspirin and Antiplatelet Drugs on the Outcome of the Fecal Immunochemical Test ﻿

Effect of oral anticoagulants on the outcome of faecal immunochemical test ﻿

Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe - An ECCO-EpiCom study ﻿

Fecal immunochemical test accuracy in average-risk colorectal cancer screening ﻿

Fecal immunochemical test accuracy in familial risk colorectal cancer screening ﻿

Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort ﻿

Incidencia y fenotipo al diagnóstico en la enfermedad inflamatoria intestinal. Resultados del estudio EpiCom en España ﻿

Initial Disease Course and Treatment in an Inflammatory Bowel Disease Inception Cohort in Europe: The ECCO-EpiCom Cohort ﻿

Intestinal cancer in inflammatory bowel disease: natural history and surveillance guidelines ﻿

Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: Results of a nationwide Spanish registry ﻿

Participación en programas de cribado de cáncer colorrectal: ¿qué factores influyen? ﻿

Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening ﻿

Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer ﻿

Prevención de la recurrencia post-quirúrgica en la enfermedad de Crohn. ¿Estamos preparados para una estrategia ôtreat-to-targetö? ﻿

Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn's disease: Predictors of efficacy in clinical practice

Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening

Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I)

Consulta telemática realizada por Enfermería en pacientes con enfermedad inflamatoria intestinal: Valoración de su capacidad resolutiva y costes

Diagnostic performance of fecal immunochemical test and sigmoidoscopy for advanced right-sided colorectal neoplasms

East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort

Effect of Aspirin and Antiplatelet Drugs on the Outcome of the Fecal Immunochemical Test

Effect of oral anticoagulants on the outcome of faecal immunochemical test

Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe - An ECCO-EpiCom study

Fecal immunochemical test accuracy in average-risk colorectal cancer screening

Fecal immunochemical test accuracy in familial risk colorectal cancer screening

Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort

Incidencia y fenotipo al diagnóstico en la enfermedad inflamatoria intestinal. Resultados del estudio EpiCom en España

Initial Disease Course and Treatment in an Inflammatory Bowel Disease Inception Cohort in Europe: The ECCO-EpiCom Cohort

Intestinal cancer in inflammatory bowel disease: natural history and surveillance guidelines

Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: Results of a nationwide Spanish registry

Participación en programas de cribado de cáncer colorrectal: ¿qué factores influyen?

Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening

Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer

Prevención de la recurrencia post-quirúrgica en la enfermedad de Crohn. ¿Estamos preparados para una estrategia ôtreat-to-targetö?